Joint Force diagnosed with Arthritis By Joe Zieja On

New Post Public Reply Private Reply Replies (4) Message Board
Bhawks
220
Quote:
Joint Force diagnosed with Arthritis


By Joe Zieja On Jul 2, 2017

doctor-soldier-750x430.jpg

doctor-soldier

KANDAHAR, Afghanistan — After more than a decade tromping through the deserts and mountains of Afghanistan, the Joint Force has been diagnosed with arthritis, according to a publicly-released medical examination.

“We are stunned and dismayed by this news,” Gen. John Nicholson said in a statement. “We are currently unsure how it will affect operations in the area. For now we’ve applied alternating hot and cold compresses and are just letting it all sink in.”

“This isn’t exactly news,” said Military Assistance Command, Vietnam (MACV) in a candid interview, now nearly 60 years old itself. “It’s part of life. You know how it goes.

The Afghan Army leaves the nest to go out on its own. AARP leaflets start coming in the mail. Then you just sort of start slowing down, you know? You can see it in the way they bend over to pick up troops in hot LZs, the way GBUs keep slipping out of their hands. Little things.”

Harsh criticism has been levied at the commanders in the region for the way it continually asked the Joint Force to accomplish demanding tasks. Many claim that routinely being forced to carry the load of NATO, the UN, and the Afghan military on its back caused the Joint Force’s cartilage to wear down over time. Others believe that the disease is mostly genetic.

The Joint Force itself seems optimistic about the diagnosis and the future outlook.

“Arthritis happens to lots of folks who go on to lead normal lives,” the Joint Force said. “We might be old, but hey, at least we don’t have dementia yet, right? When we start saying things like we have a secret plan to win the war in 30 days, you go ahead and put us down.”

According to doctors, the Joint Force had been taking 8,000 kilograms of Motrin daily to try and stave off the pain, but it’s “just not working anymore.”

The Joint Force expressed excitement at the idea of getting a high percentage disability rating from the US Department of Veterans Affairs, but was dismayed to learn that it may have to wait until the third decade of the Afghanistan conflict before the paperwork would clear.

Read more: http://www.duffelblog.com/2017/07/joint-force...z4lmOaVtD6
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading